Fundraising Fox

NuShores Biosciences

Little Rock, US · Arkansas LLC

NuShores Biosciences is a medical device company developing first-to-market technologies, with a focus on bone and tissue regeneration and joint replacement applications. It operates in the biosciences and orthopaedic/regenerative medicine field.

Founders & leadership

AS
Alexandru S. BirisCo-Founder & CTO
AG
Andrew G. KumpurisFounder and Advisor
DE
David E. AndersonCo-Founder and Advisor
SB
Sharon BallardNamed on SEC filing
AS
Alex S. BirisNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$2.6M disclosed across 2 rounds · 2017–2020

$1.5MraisedMar 2022 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sharon BallardExecutive Officer, Director
  • Alex BirisExecutive Officer, Director
Offering amount
$6M
Amount sold
$1.5M
Minimum investment
$50K
First sale
Jul 2020
Incorporated
Limited Liability Company, Arkansas
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.1MraisedJan 2019 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sharon BallardExecutive Officer, Director
  • Alex S. BirisExecutive Officer, Director
Offering amount
$1.3M
Amount sold
$1.1M
Minimum investment
$10K
First sale
Apr 2017
Incorporated
Limited Liability Company, Arkansas
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Companies competing with NuShores Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2021$3M
National Institutes of Health (NIH)National Institutes of HealthPhase II2019$1.7M
National Institutes of Health (NIH)National Institutes of HealthPhase I2018$225K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does NuShores Biosciences do?
NuShores Biosciences is a medical device company developing first-to-market technologies, with a focus on bone and tissue regeneration and joint replacement applications. It operates in the biosciences and orthopaedic/regenerative medicine field.
Who founded NuShores Biosciences?
NuShores Biosciences was founded by Alexandru S. Biris, Andrew G. Kumpuris, David E. Anderson.
How much funding has NuShores Biosciences raised?
NuShores Biosciences has disclosed $2.6M raised across 2 rounds.
Where is NuShores Biosciences headquartered?
NuShores Biosciences is headquartered in Little Rock, US.